Clin2
NCT07727473Possibly a fitNot yet recruiting

Semaglutide before prostate removal surgery

Prostate Cancer

Treatments studied

Part of Cancer, Kidney & urinary clinical trials.

This study tests whether taking semaglutide, a weight-loss medicine, for 3-6 months before prostate surgery is safe and might improve recovery by helping with weight loss.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be a man aged 18 or older.
  • You must have intermediate-risk prostate cancer that has been confirmed by biopsy.
  • You are planning to have your prostate removed, and your doctor agrees to wait 3-6 months before surgery.
  • Your body mass index (BMI) must be over 35 (clinically severe obesity).
  • You must not have taken certain hormone treatments or GLP-1 medicines like semaglutide in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06759701Recruiting· Early Phase 1
Weight loss drug before prostate cancer surgery pilot study

This study tests if taking tirzepatide (a weight loss medicine) before prostate removal surgery is safe and helpful for overweight men with intermediate-risk prostate cancer. It aims to see if losing weight can improve surgery outcomes.

Houston, Texas
NCT07859137Not yet recruiting· Phase 4
Semaglutide before weight-loss surgery for very high BMI

This trial tests whether taking a weekly injection called semaglutide (a type of medicine used for weight loss) for about 16 weeks before weight-loss surgery can help people with a very high BMI prepare for surgery. It may reduce liver fat and make surgery safer, which could lead to better outcomes.

Alexandria
NCT07859163Not yet recruiting· Phase 4
Semaglutide before and after weight-loss revision surgery

This study tests whether taking semaglutide (a once-weekly injection that helps control appetite and blood sugar) before and after a second weight-loss surgery can help people who regained weight after an initial sleeve gastrectomy. The goal is to see if the medicine improves weight-loss outcomes compared to surgery alone.

Alexandria
NCT07859189Not yet recruiting· Phase 4
Early versus delayed semaglutide after weight-loss surgery

This study tests whether starting semaglutide (a weekly injection that helps with weight loss) soon after surgery works better than waiting to see if you need it. If you have not lost enough weight one year after your surgery, this trial may help you decide the best time to start this medication.

Alexandria
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

NCT07323134Not yet recruiting
Semaglutide and gut bacteria in people with obesity

This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.